MAPK8IP2: A Potential Drug Target for Cellular Signaling Pathways

Target Name: MAPK8IP2

NCBI ID: G23542

MAPK8IP2

MAPK8IP2: A Potential Drug Target for Cellular Signaling Pathways

MAPK8IP2, also known as JNK MAP kinase scaffold protein 2, is a protein that plays a crucial role in cellular signaling pathways. It is a key regulator of the MAPK/ERK signaling pathway, which is involved in various cellular processes such as cell growth, differentiation, and survival. The MAPK/ERK signaling pathway is also known as the RAS/MAPK pathway, and it is a well-established framework for many cellular processes.

MAPK8IP2 is a protein that is expressed in various cell types, including neurons, muscle cells, and epithelial cells. It is a 21-kDa protein that consists of 205 amino acid residues. The protein has a unique structure, with a catalytic domain and a scaffold domain. The catalytic domain is responsible for the kinetic activity of the protein, while the scaffold domain plays a structural role.

The MAPK8IP2 function is to regulate the MAPK/ERK signaling pathway. It does this by interacting with the protein p21, which is a key transcription factor that is involved in cell growth and differentiation. The MAPK8IP2-p21 interaction allows the MAPK8IP2 to regulate the activity of p21, which in turn regulates the expression of genes involved in the MAPK/ERK signaling pathway.

MAPK8IP2 is also involved in the regulation of cell adhesion, migration, and invasion. It has been shown to play a role in the regulation of tight junction formation in epithelial cells, and it is also involved in the regulation of cancer cell migration and invasion.

In addition to its role in cellular signaling pathways, MAPK8IP2 is also a potential drug target. Several studies have shown that inhibiting the activity of MAPK8IP2 can be effective in treating various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

One of the reasons for the potential of MAPK8IP2 as a drug target is its involvement in the regulation of cellular signaling pathways. Many diseases are caused by the misregulation of cellular signaling pathways, and MAPK8IP2 plays a key role in regulating these pathways. By inhibiting the activity of MAPK8IP2, researchers can target the pathways that are involved in the development and progression of many diseases.

Another reason for the potential of MAPK8IP2 as a drug target is its role in the regulation of cell adhesion, migration, and invasion.MAPK8IP2 has been shown to play a role in the regulation of tight junction formation in epithelial cells, which is critical for the regulation of cell adhesion. By inhibiting the activity of MAPK8IP2, researchers can target the regulation of cell adhesion and may be able to develop new treatments for diseases such as cancer, neurodegenerative diseases, and psychiatric disorders.

In conclusion, MAPK8IP2 is a protein that plays a crucial role in cellular signaling pathways, including the regulation of the MAPK/ERK signaling pathway. It is also involved in the regulation of cell adhesion, migration, and invasion. As a result, it is a potential drug target for the treatment of various diseases. Further research is needed to fully understand the role of MAPK8IP2 in cellular signaling pathways and its potential as a drug target.

Protein Name: Mitogen-activated Protein Kinase 8 Interacting Protein 2

Functions: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module. JIP2 inhibits IL1 beta-induced apoptosis in insulin-secreting cells. May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins (By similarity)

The "MAPK8IP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAPK8IP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets